Tower Research Capital (TRC)’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $58.7K | Buy |
|
|||||
|
2025
Q4 | $9.38K | Sell |
|
|||||
|
2025
Q3 | $44.9K | Sell |
|
|||||
|
2025
Q2 | $61.6K | Buy |
|
|||||
|
2025
Q1 | $42.8K | Sell |
|
|||||
|
2024
Q4 | $107K | Buy |
|
|||||
|
2024
Q3 | $28.8K | Sell |
|
|||||
|
2024
Q2 | $70.2K | Buy |
|
|||||
|
2024
Q1 | $5.54K | Sell |
|
|||||
|
2023
Q4 | $104K | Sell |
|
|||||
|
2023
Q3 | $139K | Buy |
|
|||||
|
2023
Q2 | $32.9K | Buy |
|
|||||
|
2023
Q1 | $23K | Buy |
|
|||||
|
2022
Q4 | $12K | Sell |
|
|||||
|
2022
Q3 | $22K | Buy |
|
|||||
|
2022
Q2 | $19K | Sell |
|
|||||
|
2022
Q1 | $55K | Sell |
|
|||||
|
2021
Q4 | $90K | Buy |
|
|||||
|
2021
Q3 | $17K | Sell |
|
|||||
|
2021
Q2 | $20K | Sell |
|
|||||
|
2021
Q1 | $34K | Buy |
|